HCA Healthcare, Inc.·4

Feb 2, 8:14 PM ET

YUSPEH ALAN R 4

4 · HCA Healthcare, Inc. · Filed Feb 2, 2018

Insider Transaction Report

Form 4
Period: 2018-01-31
YUSPEH ALAN R
SVP & Chief Ethics Officer
Transactions
  • Sale

    Common Stock

    2018-01-31$100.61/sh15,000$1,509,15222,656 total
  • Award

    Stock Appreciation Right

    2018-01-31+13,73013,730 total
    Exercise: $101.16From: 2019-01-31Exp: 2028-01-31Common Stock (13,730 underlying)
Footnotes (2)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $100.32 to $100.75, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F2]The stock appreciation rights vest in four equal annual installments beginning on January 31, 2019.

Documents

2 files
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION

  • EX-24.4_766139

    POA DOCUMENT